Side effects of antihypertensive drugs.
D000317:Adrenergic alpha-Antagonists / Q000009:adverse effects / Q000627:therapeutic use; D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001581:Benzothiadiazines / Q000009:adverse effects / Q000627:therapeutic use; D050260:Carbohydrate Metabolism; D004231:Diuresis; D004232:Diuretics / Q000494:pharmacology; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D007008:Hypokalemia / Q000139:chemically induced; D007684:Kidney Tubules / Q000187:drug effects; D008138:Loop of Henle / Q000187:drug effects; D009399:Nephrons / Q000187:drug effects; D011188:Potassium / Q000378:metabolism; D049993:Sodium Chloride Symporter Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D013565:Sympatholytics / Q000009:adverse effects / Q000627:therapeutic use; D014527:Uric Acid / Q000378:metabolism; D014665:Vasodilator Agents / Q000009:adverse effects / Q000627:therapeutic use
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D001581:Benzothiadiazines; D004232:Diuretics; D049993:Sodium Chloride Symporter Inhibitors; D013565:Sympatholytics; D014665:Vasodilator Agents; D014527:Uric Acid; D011188:Potassium